Silver Grove Financial Group, Inc.
Position in PMVP — PMV Pharmaceuticals, Inc.
CIK 2111172
ORCHARD PARK, NY
Position in PMVP
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,809
+$508 QoQ
Shares Held
5,082
0.0% QoQ
Ownership
0.010%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#56
of 64 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in PMVP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Silver Grove Financial Group, Inc. holds $498,531 across 128 Biotechnology names. PMVP ranks #19 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
241 | $119,711 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
37 | $23,070 | |
| 3 | PTGX |
Protagonist Therapeutics, Inc
|
149 | $18,264 | |
| 4 | ORKA |
Oruka Therapeutics, Inc.
|
182 | $17,320 | |
| 5 | CYTK |
Cytokinetics Inc
|
180 | $15,334 | |
| 6 | PHAR |
Pharming Group N.V.
|
1,071 | $14,876 | |
| 7 | ANAB |
Anaptysbio, Inc
|
205 | $13,837 | |
| 8 | ZBIO |
Zenas BioPharma, Inc.
|
538 | $13,654 |
All Filings in PMVP
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,809 | 5,082 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $6,301 | 5,082 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $6,351 | 5,082 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||